Takeda Pharmaceutical Company’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$364K	Sell	41,165 -1	-0%	-$9	1.86%	7
2025 Q1	$443K	Hold	41,166	–	–	2.74%	7
2024 Q4	$527K	Buy	+41,166	New	+$527K	1.98%	7